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SUMO (small ubiquitin-related modifier)  is a highly conserved eukaryotic member of the family of ubiquitin-related proteins. Despite  limited sequence similarity, SUMO and 
ubiquitin have highly homologous structures (i.e., with a root-mean-square deviation [rmsd] difference of 2.1 Å). Like ubiquitin, SUMO is covalently attached to other proteins 
(SUMOylation) and thus functions as a posttranslational modifier. Although a major function of ubiquitination is to promote protein degradation, SUMOylation does not usually 
trigger proteolyis of the conjugated protein. Instead, a main function of SUMOylation is to foster—and occasionally disrupt—protein-protein interactions.
Although less frequent than ubiquitination, SUMOylation regulates numerous processes and has many substrates in the cytosol and the nucleus. Lower eukaryotes possess 
only one SUMO form, but higher eukaryotes express several, perhaps functionally distinct, SUMO variants. In most organisms, SUMO is essential for viability. This SnapShot 
depicts the reactions involved in SUMO ligation, the effects of SUMOylation on target proteins, and cellular processes regulated by SUMOylation.
SUMO Enzymology
Similar to ubiquitination, SUMOylation requires ATP and a series of enzymes for conjugation (Table A). SUMO is initially produced as an inactive precursor, which is then pro-
cessed at the C terminus by SUMO-specific proteases (yeast Ulp1, mammalian SENPs), giving rise to mature SUMO with a C-terminal Gly-Gly motif. Conjugation involves at least 
two enzymes, an ATP-dependent activating enzyme (E1, a heterodimer) and a conjugating enzyme (E2, Ubc9). SUMO is linked to these enzymes by the formation of a thioester 
bond between SUMO’s C terminus and cysteine residues in the active sites of these enzymes. For some substrates, SUMOylation further requires specific SUMO ligases (E3).
SUMOylation targets lysine residues (by isopeptide formation), often, but not always, within a consensus site ΨKxE/D in which Ψ is a hydrophobic amino acid. In some cases, 
phosphorylation of Ser or Thr residues downstream of the consensus site enhances SUMOylation. Substrates can be modified by one SUMO (monoSUMOylation) or several 
SUMO molecules at several  lysine residues (multiple monoSUMOylation). Moreover, proteins can also be modified by a chain of SUMO (polySUMOylation),  in which several 
SUMO moieties are conjugated to each other. However, the functional relevance of these different types of SUMO modifications is not clear. Like ubiquitination, SUMOylation 
is reversible due to the presence of deSUMOylation enzymes (SUMO-specific proteases). Typically, for a given substrate, only a small portion of the molecules present in a cell 
(usually <5%) is SUMOylated at steady state because SUMOylation is reversible and usually acts in a switch-like manner to trigger temporary changes.
SUMO-Interaction Motifs
The SUMO modification is recognized by SUMO-interaction motifs (SIMs) of downstream effector proteins (Table B). SIMs are very short motifs with a hydrophobic core (3 to 4 
amino acids) followed (or preceded) by a stretch of 2–5 acidic amino acids. Phospho-dependent SIMs (phospho-SIMs) are SIM variants that exhibit affinity for SUMO only after 
phosphorylation.
SUMO Mechanisms
SUMOylation affects proteins in three different ways (Table C). In most cases, SUMOylation recruits other proteins (acting as “glue”), often by enhancing pre-existing affinities. If 
several proteins have SUMOylation sites and SIMs, mutual recruitment can result in complex formation, as is the case during formation of PML (promyelocytic leukemia protein) 
nuclear bodies. However, in a few cases, the bulky SUMO modification actually blocks binding of partner proteins (acting as “repellent”) if the SUMOylation site is close to or 
overlapping with a protein-binding site.
X-ray crystallography has shown that the structure of the substrate is normally unchanged by SUMOylation. One notable exception is the DNA repair protein TDG (thymine 
DNA glycosylase), which undergoes a conformational change upon SUMOylation, and this conformational change is functionally important.
SUMO-Ubiquitin Crosstalk
Although SUMOylation and ubiquitination are largely independent from each other, there is growing evidence for crosstalk between the two pathways (Table D). For example, 
when both modifiers target the same lysine residue, such as on the proliferating cell nuclear antigen (PCNA) protein, the sequential ligation of SUMO and ubiquitin may determine 
the order of recruitment of SUMO- and ubiquitin-binding proteins. Another example is IκBα, which can be SUMOylated (and stabilized) whereas its ubiquitination triggers its 
degradation. In an interesting variation, SUMO-targeted ubiquitin ligases (STUbLs) are ubiquitin ligases that contain a SIM motif and specifically target SUMOylated substrates 
such as PML. STUbLs may recognize multiple monoSUMOylated or polySUMOylated substrates. Additional crosstalk is suggested by the finding that enzymes from one system 
(e.g., the deubiquitinating enzyme Usp25) are sometimes modified by modifiers from the other system (in the case of Usp25, SUMO) and vice versa.
SUMO Functions
Genetic and biochemical screens, assisted by mass spectrometry of conjugates, led to the identification of numerous SUMO substrates and many cellular functions (Table E). 
For example, the cytosolic domains of some plasma membrane proteins and signaling proteins are modified by SUMOylation. SUMOylation of the septins in yeast may play a 
role in cytokinesis, whereas SUMOylation of the mammalian potassium channel KCNA5 modulates channel activity by altering the voltage-dependent inactivation of the chan-
nel. Furthermore, SUMOylation of Smad4 (mothers against decapentaplegic homolog 4) and IκBα appear to regulate their respective signaling pathways. In the case of IκBα, 
SUMOylation stabilizes the protein. Also proteins of the outer membrane of the mitochondria can be SUMOylated, but the function is unclear.
The nuclear pore complex appears to be a hub for SUMOylation and deSUMOylation. Whether these activities are important for substrate translocation or whether proteins 
passing through the pore are modified or demodified remains  largely unknown. However, SUMOylation of Ran-GTPase-activating protein 1 (RanGAP1) by the SUMO ligase 
RanBP2 is known to regulate its localization at the pore.
SUMOylation is highly active in the nucleus, perhaps triggering complex formation among nuclear proteins or even promoting subcompartmentalization of the nucleus. A well-
studied case is the PML nuclear body. Components of this structure, including PML and Sp100, contain both SUMOylation and SIM sites, leading to the recruitment of additional 
proteins. However, under certain conditions, polySUMOylation of PML occurs, triggering ubiquitination and subsequent proteasomal degradation of PML. Another SUMOylation 
hub appears to be the nucleolus, where SUMOylation events assist in rRNA processing and ribosome biogenesis.
SUMOylation reactions also affect chromosome function. SUMOylation regulates kinetochores, centromeres, and telomeres, as well as the formation and stability of synap-
tonemal complexes in meiosis. SUMOylation of transcription factors often leads to transcriptional repression via the recruitment of corepressors. SUMOylation of DNA repair 
proteins regulates all major DNA repair pathways. For example, SUMOylation of the DNA repair protein Rad52 prevents uncontrolled recombination between ribosomal RNA 
(rRNA) genes in the nucleolus. In the case of the replication protein PCNA, its SUMOylation leads to the recruitment of an inhibitor of homologous recombination. On the other 
hand, the same modification inhibits the recruitment of other factors to PCNA, such as Eco1, a regulator of sister chromatid cohesion.
Analyzing the function of SUMOylation is often challenging, even if the target lysine is known. One reason may be redundancy; protein complexes may be held together by 
several SUMO-SIM interactions, and elimination of one SUMOylation site may thus have no major consequences. This network-like property may be crucial for signaling path-
ways and may even give directionality to some processes such as DNA repair. Moreover, SUMOylation may concentrate enzymatic activities or trigger formation of large nuclear 
assemblies such as PML bodies and possibly repair foci.
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